Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 5 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//PSYCHOLOGY, EXPERIMENTAL | 1830502 |
| 251 | 3 | ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH//SUBSTANCE ABUSE//ALCOHOL | 46469 |
| 1923 | 2 | FETAL ALCOHOL SYNDROME//FETAL ALCOHOL SPECTRUM DISORDERS//PRENATAL ALCOHOL EXPOSURE | 6198 |
| 27396 | 1 | ADAMS SUPER BRAIN STUDIES//LILY AVRAHAM GILDOR CHAIR INVEST GROWTH TORS//ACTIVITY DEPENDENT NEUROPROTECTIVE PROTEIN | 250 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | ADAMS SUPER BRAIN STUDIES | address | 3212794 | 12% | 88% | 29 |
| 2 | LILY AVRAHAM GILDOR CHAIR INVEST GROWTH TORS | address | 2346781 | 9% | 85% | 22 |
| 3 | ACTIVITY DEPENDENT NEUROPROTECTIVE PROTEIN | authKW | 1821664 | 7% | 85% | 17 |
| 4 | SECT DEV MOL PHARMACOL | address | 1647247 | 11% | 47% | 28 |
| 5 | ADNP | authKW | 1584052 | 7% | 74% | 17 |
| 6 | ACTIVITY DEPENDENT NEUROPROTECTIVE PROTEIN ADNP | authKW | 1575834 | 6% | 83% | 15 |
| 7 | DAVUNETIDE | authKW | 1050556 | 4% | 83% | 10 |
| 8 | NAP DAVUNETIDE | authKW | 882470 | 3% | 100% | 7 |
| 9 | NAP | authKW | 697233 | 14% | 16% | 34 |
| 10 | ELTON NEUROENDOCRINOL | address | 648343 | 2% | 86% | 6 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Neurosciences | 2089 | 53% | 0% | 132 |
| 2 | Biochemistry & Molecular Biology | 352 | 33% | 0% | 83 |
| 3 | Pharmacology & Pharmacy | 242 | 20% | 0% | 50 |
| 4 | Psychiatry | 130 | 9% | 0% | 23 |
| 5 | Endocrinology & Metabolism | 53 | 7% | 0% | 17 |
| 6 | Obstetrics & Gynecology | 36 | 4% | 0% | 11 |
| 7 | Developmental Biology | 26 | 2% | 0% | 6 |
| 8 | Behavioral Sciences | 12 | 2% | 0% | 5 |
| 9 | Substance Abuse | 11 | 1% | 0% | 3 |
| 10 | Clinical Neurology | 10 | 4% | 0% | 11 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ADAMS SUPER BRAIN STUDIES | 3212794 | 12% | 88% | 29 |
| 2 | LILY AVRAHAM GILDOR CHAIR INVEST GROWTH TORS | 2346781 | 9% | 85% | 22 |
| 3 | SECT DEV MOL PHARMACOL | 1647247 | 11% | 47% | 28 |
| 4 | ELTON NEUROENDOCRINOL | 648343 | 2% | 86% | 6 |
| 5 | U366 | 585587 | 5% | 39% | 12 |
| 6 | CYTOSQUELETTE | 575803 | 5% | 35% | 13 |
| 7 | DR DIANA ZELMAN ELTON ELBAUM MOL NEUROENDOC | 525278 | 2% | 83% | 5 |
| 8 | HUMAN MOL GENET BIOCHEMSACKLER MED | 403413 | 2% | 80% | 4 |
| 9 | ELTON NEUROENDOCRINOL HUMAN MOL GENET | 378201 | 1% | 100% | 3 |
| 10 | ELTON NEUROENDOCRINOLSAGOL NEUROSCI | 378201 | 1% | 100% | 3 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | JOURNAL OF MOLECULAR NEUROSCIENCE | 37579 | 12% | 1% | 29 |
| 2 | PEPTIDES | 1419 | 4% | 0% | 10 |
| 3 | MOLECULAR PSYCHIATRY | 1307 | 2% | 0% | 5 |
| 4 | NEUROBIOLOGY OF DISEASE | 1188 | 2% | 0% | 6 |
| 5 | JOURNAL OF NEUROCHEMISTRY | 848 | 5% | 0% | 12 |
| 6 | CNS DRUG REVIEWS | 771 | 0% | 1% | 1 |
| 7 | NEURON GLIA BIOLOGY | 651 | 0% | 1% | 1 |
| 8 | JOURNAL OF ALZHEIMERS DISEASE | 626 | 2% | 0% | 5 |
| 9 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 582 | 4% | 0% | 10 |
| 10 | AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 490 | 4% | 0% | 9 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |